Post-Transplant Cyclophosphamide (PTC) as Sole Graft Versus Host Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling Donor Stem Cell Transplant (SCT) for Severe Aplastic Anemia (SAA)

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.491
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in HLA Matched Sibling or Matched Unrelated Donor Transplant for Patients With Acute Leukemia, on Behalf of ALWP-EBMT

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Neurocognitive Functioning in Adults Who Underwent Nonmyeloablative HLA-Matched Sibling Hematopoietic Stem Cell Transplant (SCT) for Sickle Cell Disease (SCD)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Calcineurin and M-Tor Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-Ii Study

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Myasthenia Gravis Presenting as Graft Versus Host Disease After Allogeneic Blood Stem Cell Transplant

Case Reports in Hematology
2018English

Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated With Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy